New: NCI-funded clinical trial search
Mednet Logo

During NIT-based monitoring, how do you interpret and act on discordant or modest changes between VCTE and ELF (e.g., <30% VCTE improvement with a small ELF decline, or the reverse), and what degree/pattern of change prompts you to add or switch therapy rather than continue observation?